DeepMed Research

National Heart, Lung, and Blood Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study of the Disease Process of Lymphangioleiomyomatosis

Recruiting

Conditions: Pneumothorax
Lymphangioleiomyomatosis
Lung Disease
Tuberous Sclerosis

Interventions: Device: Toshibia Aquilion One CT

First Posted Date: 1999-11-04

Last Posted Date: 2025-05-16

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 2000

Registration Number: NCT00001465

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Screening for Hematology Branch Protocols

Conditions: Healthy Volunteer
Hematologic Disease and Disorders
Donors

First Posted Date: 1999-11-04

Last Posted Date: 2025-05-20

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 10000

Registration Number: NCT00001620

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins

Completed

Conditions: Hypolipoproteinemia
Hypercholesterolemia
Dyslipidemia
Hyperlipidemia

First Posted Date: 1999-11-04

Last Posted Date: 2025-05-21

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 759

Registration Number: NCT00001154

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Evaluation of Lipoproteins

Completed

Conditions: Evaluation of Plasma Lipoproteins

Interventions: Behavioral: Balanced diet

First Posted Date: 1999-11-04

Last Posted Date: 2025-05-20

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Target Recruit Count: 1017

Registration Number: NCT00001168

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Cooperative Study of Factor VIII Inhibitors

Phase 3

Completed

Conditions: Blood Coagulation Disorders
Hematologic Diseases
Hemophilia A
Hemorrhagic Disorders

First Posted Date: 1999-10-28

Last Posted Date: 2012-04-27

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Registration Number: NCT00000582

Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)

Phase 2

Completed

Conditions: Cardiovascular Diseases
Heart Diseases
Hypertension
Vascular Diseases

First Posted Date: 1999-10-28

Last Posted Date: 2013-11-26

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Registration Number: NCT00000499

Trials of Hypertension Prevention (TOHP)

Phase 3

Completed

Conditions: Cardiovascular Diseases
Heart Diseases
Hypertension
Vascular Diseases

First Posted Date: 1999-10-28

Last Posted Date: 2016-03-16

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Registration Number: NCT00000528

Stress Reduction and Atherosclerotic CVD in Blacks

Phase 3

Completed

Conditions: Heart Diseases
Hypertension
Cardiovascular Diseases
Coronary Disease
Vascular Diseases

First Posted Date: 1999-10-28

Last Posted Date: 2016-02-18

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Registration Number: NCT00000546

Prevention and Treatment of Hypertension Study (PATHS)

Phase 3

Completed

Conditions: Cardiovascular Diseases
Heart Diseases
Hypertension
Vascular Diseases

First Posted Date: 1999-10-28

Last Posted Date: 2016-07-12

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Registration Number: NCT00000474

Oral Calcium in Pregnant Women With Hypertension

Phase 2

Completed

Conditions: Pregnancy Toxemias
Vascular Diseases
Cardiovascular Diseases
Heart Diseases
Hypertension
Pre-Eclampsia

First Posted Date: 1999-10-28

Last Posted Date: 2016-05-13

Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Registration Number: NCT00000543

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy